Status:
COMPLETED
Post-Market Clinical Survey of Clareon® IOL AutonoMe™ in Japanese Subjects
Lead Sponsor:
Alcon Research
Conditions:
Cataract
Eligibility:
All Genders
20+ years
Brief Summary
This purpose of this survey study is to collect and describe clinical outcomes for the intraocular lens (IOL) delivery performance of Clareon® IOL AutonoMe™ when used in daily practice.
Detailed Description
This study will enroll subjects who underwent prior cataract surgery with phacoemulsification and were implanted with Clareon intraocular lenses (IOLs) using the Clareon® IOL AutonoMe™ automated prelo...
Eligibility Criteria
Inclusion
- Able to comprehend and willing to sign informed consent.
- Prior diagnosis of age-related cataracts.
- Prior cataract surgery with implantation of Clareon IOL in the capsular bag by AutonoMe™.
- No ophthalmic disease which might affect visual acuity.
Exclusion
- None.
Key Trial Info
Start Date :
February 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 20 2020
Estimated Enrollment :
384 Patients enrolled
Trial Details
Trial ID
NCT03824028
Start Date
February 10 2019
End Date
October 20 2020
Last Update
March 10 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Alcon Investigative Site
Yokohama, Kanagawa, Japan, 220-0011
2
Alcon Investigative Site
Yokkaichi, Mie-ken, Japan, 510-0085
3
Alcon Investigative Site
Hashimoto, Wakayama, Japan, 648-0073